Arndt Vogel Selected Research

Colorectal Neoplasms (Colorectal Cancer)

2/2024	Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer.
11/2023	Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
11/2021	[BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version].
11/2021	BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options.
10/2018	Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists.
6/2018	First-line molecular therapies in the treatment of metastatic colorectal cancer - a literature-based review of phases II and III trials.
1/2018	[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].
1/2017	Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review.
1/2015	Improving patient outcomes with regorafenib for metastatic colorectal cancer - patient selection, dosing, patient education, prophylaxis, and management of adverse events.
11/2014	Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arndt Vogel Research Topics

Disease

83	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 10/2009
69	Neoplasms (Cancer) 03/2024 - 08/2008
18	Fibrosis (Cirrhosis) 09/2023 - 09/2009
15	Cholangiocarcinoma 01/2023 - 10/2014
12	Disease Progression 05/2024 - 07/2014
12	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 08/2014
12	Liver Diseases (Liver Disease) 01/2023 - 02/2004
10	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2014
9	Neoplasm Metastasis (Metastasis) 11/2019 - 07/2013
8	Inflammation (Inflammations) 03/2024 - 12/2012
8	Liver Neoplasms (Liver Cancer) 10/2023 - 10/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 06/2003
7	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 09/2017
5	Fatigue 08/2023 - 01/2015
5	Hypertension (High Blood Pressure) 01/2023 - 01/2015
5	Adenocarcinoma 01/2022 - 06/2003
5	Autoimmune Hepatitis 01/2020 - 01/2002
4	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
3	Thrombocytopenia (Thrombopenia) 07/2023 - 10/2021
3	Hepatitis B 01/2022 - 07/2014
3	Uveal melanoma 12/2021 - 06/2017
3	Cholestasis 12/2021 - 01/2006
3	Infections 02/2019 - 12/2012
2	Overweight 08/2023 - 01/2022
2	Hemorrhage 07/2023 - 01/2021
2	Portal Hypertension 01/2023 - 01/2021
2	Liver Failure 02/2022 - 04/2008
2	Hepatitis 01/2022 - 02/2006
2	Neutropenia 10/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 11/2014
2	Carcinoma (Carcinomatosis) 11/2020 - 02/2020
2	Asthenia 08/2020 - 07/2014
2	Ascites 08/2020 - 01/2017
2	Fatty Liver 01/2020 - 11/2016
2	Tyrosinemias (Tyrosinemia) 10/2019 - 08/2008
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

21	Sorafenib (BAY 43-9006)FDA Link 12/2023 - 06/2014
16	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2003
14	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
14	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2021
14	atezolizumabIBA 12/2023 - 10/2018
13	Gemcitabine FDA Link 05/2024 - 08/2014
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2006
9	pembrolizumabIBA 01/2024 - 01/2018
8	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 05/2013
8	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2017
8	lenvatinibIBA 06/2022 - 01/2018
6	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 05/2005
6	BilirubinIBA 10/2023 - 01/2015
5	AlbuminsIBA 10/2023 - 01/2008
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2022 - 01/2020
5	Everolimus FDA Link 11/2020 - 08/2009
4	durvalumabIBA 05/2024 - 10/2018
4	Tyrosine Kinase InhibitorsIBA 09/2023 - 01/2015
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 09/2009
4	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2014
4	RamucirumabIBA 10/2021 - 01/2020
4	130-nm albumin-bound paclitaxelIBA 01/2021 - 11/2014
4	AntibodiesIBA 11/2018 - 11/2014
3	NivolumabIBA 01/2022 - 10/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 06/2003
3	MicroRNAs (MicroRNA)IBA 03/2017 - 08/2013
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2015 - 12/2012
3	AutoantibodiesIBA 02/2006 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2020
2	CytokinesIBA 02/2024 - 12/2015
2	tislelizumabIBA 10/2023 - 06/2019
2	Messenger RNA (mRNA)IBA 07/2022 - 12/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2018
2	AcyltransferasesIBA 01/2022 - 10/2018
2	SirtuinsIBA 08/2021 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2009
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2020
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2020
2	PlatinumIBA 11/2020 - 08/2014
2	pemigatinibIBA 10/2020 - 01/2020
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2020 - 01/2018
2	Phospholipases (Phospholipase)IBA 01/2020 - 10/2018
2	Monoclonal AntibodiesIBA 06/2019 - 11/2014
2	Antiviral Agents (Antivirals)IBA 02/2019 - 09/2017
2	AntigensIBA 02/2019 - 02/2006
2	VemurafenibIBA 01/2019 - 01/2018
2	Cholinesterases (Cholinesterase)IBA 01/2019 - 01/2017
2	Panitumumab (Vectibix)FDA Link 06/2018 - 01/2018
2	Cetuximab (Erbitux)FDA Link 06/2018 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 06/2014

Therapy/Procedure

74	Therapeutics 03/2024 - 02/2004
15	Immunotherapy 02/2024 - 01/2019
13	Drug Therapy (Chemotherapy) 11/2023 - 08/2014
12	Liver Transplantation 01/2023 - 02/2004
3	Hemofiltration 08/2021 - 10/2017
3	Transplantation 11/2019 - 02/2004
2	Neoadjuvant Therapy 12/2023 - 02/2020
2	Salvage Therapy 01/2023 - 12/2021
2	Radiotherapy 08/2021 - 01/2021
2	Adjuvant Chemotherapy 02/2020 - 07/2017